These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 20704566

  • 21. Crystal structure of the botulinum neurotoxin type G binding domain: insight into cell surface binding.
    Stenmark P, Dong M, Dupuy J, Chapman ER, Stevens RC.
    J Mol Biol; 2010 Apr 16; 397(5):1287-97. PubMed ID: 20219474
    [Abstract] [Full Text] [Related]

  • 22. Location of the synaptosome-binding regions on botulinum neurotoxin B.
    Dolimbek BZ, Steward LE, Aoki KR, Atassi MZ.
    Biochemistry; 2012 Jan 10; 51(1):316-28. PubMed ID: 22146011
    [Abstract] [Full Text] [Related]

  • 23. Differential contribution of the residues in C-terminal half of the heavy chain of botulinum neurotoxin type B to its binding to the ganglioside GT1b and the synaptotagmin 2/GT1b complex.
    Kohda T, Ihara H, Seto Y, Tsutsuki H, Mukamoto M, Kozaki S.
    Microb Pathog; 2007 Jan 10; 42(2-3):72-9. PubMed ID: 17188834
    [Abstract] [Full Text] [Related]

  • 24. Sequence homology and structural analysis of the clostridial neurotoxins.
    Lacy DB, Stevens RC.
    J Mol Biol; 1999 Sep 03; 291(5):1091-104. PubMed ID: 10518945
    [Abstract] [Full Text] [Related]

  • 25. The 25 kDa HCN Domain of Clostridial Neurotoxins Is Indispensable for Their Neurotoxicity.
    Deppe J, Weisemann J, Mahrhold S, Rummel A.
    Toxins (Basel); 2020 Nov 26; 12(12):. PubMed ID: 33255952
    [Abstract] [Full Text] [Related]

  • 26. Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipid. Novel insights into the receptor for clostridial neurotoxins.
    Tsukamoto K, Kohda T, Mukamoto M, Takeuchi K, Ihara H, Saito M, Kozaki S.
    J Biol Chem; 2005 Oct 21; 280(42):35164-71. PubMed ID: 16115873
    [Abstract] [Full Text] [Related]

  • 27. Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors.
    Peng L, Tepp WH, Johnson EA, Dong M.
    PLoS Pathog; 2011 Mar 21; 7(3):e1002008. PubMed ID: 21483489
    [Abstract] [Full Text] [Related]

  • 28. Two Feet on the Membrane: Uptake of Clostridial Neurotoxins.
    Rummel A.
    Curr Top Microbiol Immunol; 2017 Mar 21; 406():1-37. PubMed ID: 27921176
    [Abstract] [Full Text] [Related]

  • 29. Mechanism of Ganglioside Receptor Recognition by Botulinum Neurotoxin Serotype E.
    Masuyer G, Davies JR, Stenmark P.
    Int J Mol Sci; 2021 Aug 02; 22(15):. PubMed ID: 34361086
    [Abstract] [Full Text] [Related]

  • 30. Unique ganglioside binding by botulinum neurotoxins C and D-SA.
    Kroken AR, Karalewitz AP, Fu Z, Baldwin MR, Kim JJ, Barbieri JT.
    FEBS J; 2011 Dec 02; 278(23):4486-96. PubMed ID: 21554541
    [Abstract] [Full Text] [Related]

  • 31. Crystal structure of botulinum neurotoxin subtype A3 cell binding domain in complex with GD1a co-receptor ganglioside.
    Gregory KS, Liu SM, Acharya KR.
    FEBS Open Bio; 2020 Mar 02; 10(3):298-305. PubMed ID: 31945264
    [Abstract] [Full Text] [Related]

  • 32. Clostridium botulinum serotype D neurotoxin and toxin complex bind to bovine aortic endothelial cells via sialic acid.
    Yoneyama T, Miyata K, Chikai T, Mikami A, Suzuki T, Hasegawa K, Ikeda T, Watanabe T, Ohyama T, Niwa K.
    FEMS Immunol Med Microbiol; 2008 Dec 02; 54(3):290-8. PubMed ID: 18801042
    [Abstract] [Full Text] [Related]

  • 33. Synaptotagmin II and gangliosides bind independently with botulinum neurotoxin B but each restrains the other.
    Atassi MZ, Taruishi M, Naqvi M, Steward LE, Aoki KR.
    Protein J; 2014 Jun 02; 33(3):278-88. PubMed ID: 24740609
    [Abstract] [Full Text] [Related]

  • 34. Unique ganglioside recognition strategies for clostridial neurotoxins.
    Benson MA, Fu Z, Kim JJ, Baldwin MR.
    J Biol Chem; 2011 Sep 30; 286(39):34015-22. PubMed ID: 21849494
    [Abstract] [Full Text] [Related]

  • 35. Tetanus toxin and botulinum toxin a utilize unique mechanisms to enter neurons of the central nervous system.
    Blum FC, Chen C, Kroken AR, Barbieri JT.
    Infect Immun; 2012 May 30; 80(5):1662-9. PubMed ID: 22392932
    [Abstract] [Full Text] [Related]

  • 36. Cell entry strategy of clostridial neurotoxins.
    Binz T, Rummel A.
    J Neurochem; 2009 Jun 30; 109(6):1584-95. PubMed ID: 19457120
    [Abstract] [Full Text] [Related]

  • 37. Identification of the SV2 protein receptor-binding site of botulinum neurotoxin type E.
    Mahrhold S, Strotmeier J, Garcia-Rodriguez C, Lou J, Marks JD, Rummel A, Binz T.
    Biochem J; 2013 Jul 01; 453(1):37-47. PubMed ID: 23621114
    [Abstract] [Full Text] [Related]

  • 38. Molecular mechanisms of substrate recognition and specificity of botulinum neurotoxin serotype F.
    Chen S, Wan HY.
    Biochem J; 2011 Jan 15; 433(2):277-84. PubMed ID: 21029044
    [Abstract] [Full Text] [Related]

  • 39. Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons.
    Dong M, Liu H, Tepp WH, Johnson EA, Janz R, Chapman ER.
    Mol Biol Cell; 2008 Dec 15; 19(12):5226-37. PubMed ID: 18815274
    [Abstract] [Full Text] [Related]

  • 40. Molecular structures and functional relationships in clostridial neurotoxins.
    Swaminathan S.
    FEBS J; 2011 Dec 15; 278(23):4467-85. PubMed ID: 21592305
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.